Innerer Wert von S&P & Nasdaq Kontaktieren

Mesa Laboratories, Inc. MLAB NASDAQ

NASDAQ Global Select • Technology • Hardware, Equipment & Parts • US • USD

SharesGrow Score
37/100
0/7 Pass
SharesGrow Intrinsic Value
$91.05
-8%
Analyst Price Target
$94.00
-5%

Mesa Laboratories, Inc. (MLAB) ist ein börsennotiertes Unternehmen im Technologie Sektor, tätig in der Hardware, Equipment & Parts Branche. Der Hauptsitz des Unternehmens ist in Lakewood, CO, United States. Der aktuelle CEO ist Gary Owens.

MLAB hat IPO-Datum 1984-02-29, 736 Vollzeitbeschäftigte, gelistet an der NASDAQ Global Select, eine Marktkapitalisierung von $546.79M.

Über Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

📍 12100 West Sixth Avenue, Lakewood, CO 80228 📞 303 987 8000
Unternehmensdetails
SektorTechnologie
BrancheHardware, Equipment & Parts
LandUnited States
BörseNASDAQ Global Select
WährungUSD
IPO-Datum1984-02-29
CEOGary Owens
Mitarbeiter736
Handelsinformationen
Aktueller Kurs$98.97
Marktkapitalisierung$546.79M
52-Wochen-Spanne55.45-131.2
Beta0.89
ETFNein
ADRNein
CUSIP59064R109
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden